DEPRESSION References

1.            Bech P. Social functioning: should it become an endpoint in trials of antidepressants? CNS Drugs 19: 313-324, 2005.

2.            Chasens ER. Obstructive sleep apnea, daytime sleepiness, and type 2 diabetes. Diabetes Educ 33: 475-482, 2007.

3.            Clayton AH. Female sexual dysfunction related to depression and antidepressant medications. Curr Womens Health Rep 2: 182-187, 2002.

4.            Doghramji K. Treatment strategies for sleep disturbance in patients with depression. J Clin Psychiatry 64 Suppl 14: 24-29, 2003.

5.            Gami AS, Caples SM, and Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32: 869-894, 2003.

6.            Greener MJ, and Guest JF. Do antidepressants reduce the burden imposed by depression on employers? CNS Drugs 19: 253-264, 2005.

7.            Gregorian RS, Golden KA, Bahce A, Goodman C, Kwong WJ, and Khan ZM. Antidepressant-induced sexual dysfunction. Ann Pharmacother 36: 1577-1589, 2002.

8.            Happe S. Excessive daytime sleepiness and sleep disturbances in patients with neurological diseases: epidemiology and management. Drugs 63: 2725-2737, 2003.

9.            Krakow B. Nightmare complaints in treatment-seeking patients in clinical sleep medicine settings: diagnostic and treatment implications. Sleep 29: 1313-1319, 2006.

10.            Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J Clin Sleep Med 3: 63-72, 2007.

11.            Labbate LA, Croft HA, and Oleshansky MA. Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J Clin Psychiatry 64 Suppl 10: 11-19, 2003.

12.            McEwen BS. Sleep deprivation as a neurobiologic and physiologic stressor: Allostasis and allostatic load. Metabolism 55: S20-23, 2006.

13.            McMahon JP, Foresman BH, and Chisholm RC. The influence of CPAP on the neurobehavioral performance of patients with obstructive sleep apnea hypopnea syndrome: a systematic review. WMJ 102: 36-43, 2003.

14.           Ness-Abramof R, and Apovian CM. Drug-induced weight gain. Drugs Today (Barc) 41: 547-555, 2005.

15.            Piechota G, Malkiewicz J, and Karwat ID. [Obesity as a cause and result of disability]. Przegl Epidemiol 59: 155-161, 2005.

16.          Pijl H, and Meinders AE. Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14: 329-342, 1996.

17.          Sateia MJ. Neuropsychological impairment and quality of life in obstructive sleep apnea. Clin Chest Med 24: 249-259, 2003.

18.            Valipour A, Lothaller H, Rauscher H, Zwick H, Burghuber OC, and Lavie P. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep 30: 312-319, 2007.

19.          White J, Cates C, and Wright J. Continuous positive airways pressure for obstructive sleep apnoea. Cochrane Database Syst Rev CD001106, 2002.

20.            Williams K, and Reynolds MF. Sexual dysfunction in major depression. CNS Spectr 11: 19-23, 2006.